En Es
Categories

Industry News

Cardinal Health to Acquire Medtronic Product Portfolio

By HospiMedica International staff writers
20 Apr 2017

Image: Medtronic has entered into an agreement with Cardinal Health to sell its patient product portfolio (Photo courtesy of iStock).Medtronic plc has entered into a definitive agreement with Cardinal Health Inc. to sell its patient care, deep vein thrombosis, and nutritional insufficiency businesses within the Patient Monitoring & Recovery (PMR) division of its Minimally Invasive Therapies Group (MITG).

Medtronic plc is a medical technology, services and solutions company that manufactures and sells device-based medical therapies worldwide. Cardinal Health is a global, integrated healthcare services and products company, providing customized solutions for hospitals, health systems, and other clinical entities worldwide.

The product lines included in the transaction are Medtronic's dental/animal health, chart paper, wound care, incontinence, electrodes, SharpSafety, thermometry, perinatal protection, blood collection, compression, and enteral feeding offerings. The transaction also includes 17 dedicated manufacturing facilities. Medtronic will retain its Respiratory & Monitoring Solutions business, which includes its airway, ventilators, monitors, sensors, and health informatics product lines, as well as its Renal Care Solutions business, both of which are within its PMR division. The USD 6.1 billion cash transaction is expected to close in Medtronic's second quarter of its fiscal year 2018, subject to receipt of customary regulatory approvals and satisfaction of other customary closing conditions.

"This is a positive transaction for all involved - Medtronic, Cardinal Health, and our respective shareholders and employees - who we believe will all thrive under this change in ownership. In addition, it signifies our commitment to disciplined portfolio management," said Omar Ishrak, Medtronic chairman and chief executive officer. "Medtronic has had a specific focus over the past several years on ensuring that we are delivering compelling clinical and economic value to health systems and patients around the world. Ultimately, we came to the conclusion that these products - while truly meaningful to patients in need - are best suited under ownership that can provide the investment and focus that these businesses require. At the same time, we can put these proceeds to work, investing over the long-term in higher returning internal and external opportunities that are more directly aligned with our growth strategies of therapy innovation, globalization, and economic value."

"This transaction enables our group to better focus on a portfolio that delivers on our global strategic priorities," said Bryan Hanson, executive vice president and president of Medtronic's Minimally Invasive Therapies Group. "We believe both our employees and these businesses will thrive under Cardinal Health's ownership. We sincerely appreciate the countless contributions of our team throughout the years, as well as the partnership and loyalty of our customers and patients."



E-mail Print
FaceBook Twitter Google+ Linked in

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neurological and musculoskeletal conditions. The company also offers products for patient monitoring, respiratory care, urological & urogynecological treatment, general surgery, and patient care.
More info

Additional news

21 Apr 2021
FDA Clears First-Ever AI Mammography Triage Software that Supports both 3D and 2D Mammography
The US Food and Drug Administration has cleared the first-ever artificial intelligence (AI) mammography triage software that supports both 3D and 2D mammography.
Read More
20 Apr 2021
Global Digital PCR and Real-Time PCR Market Growth Driven by Increasing Cases of Infectious Diseases
Increasing cases of infectious diseases, rising geriatric population and growing number of genetic disorders will propel the growth of the global digital PCR and real-time PCR market over the next decade. Additionally, PCR advances, fulfillment of the human genome project, and expanding R&D will increase the utilization of biomarker profiling for sickness diagnostics, thus further driving market growth.
Read More
19 Apr 2021
Siemens Completes Acquisition of Varian to Create Integrated Portfolio of Imaging, Laboratory Diagnostics, AI and Cancer Treatment
Siemens Healthineers (Erlangen, Germany) has successfully completed the acquisition of Varian Medical Systems, Inc. (Palo Alto, CA, USA), thus strengthening its position as a holistic partner in healthcare.
Read More
16 Apr 2021
Eppendorf Introduces Multipurpose Centrifuge 5910 Ri to Accelerate Results
Eppendorf AG (Hamburg, Germany) has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri, a successor to the company’s popular Centrifuge 5910 R.
Read More
16 Apr 2021
Artificial Intelligence (AI) in Medical Diagnostics Market to Reach USD 3.86 Billion by 2025
The global Artificial Intelligence (AI) in Medical Diagnostics Market is projected to grow at a CAGR of 50.2% from USD 0.5 billion in 2020 to USD 3.86 billion by 2025, driven primarily by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field, growing focus on reducing the workload of radiologists, influx of large and complex datasets, growth in funding for AI-based start-ups, and growing number of cross-industry partnerships and collaborations.
Read More
15 Apr 2021
Microsoft Acquires Radiology Vendor Nuance to Deliver New Cloud and AI Capabilities Across Healthcare
Microsoft Corporation (Redmond, WA, USA) will acquire Nuance Communications, Inc. (Burlington, MA, USA) in an all-cash transaction valued at USD 19.7 billion to combine their solutions and expertise that will deliver new cloud and AI capabilities across healthcare and other industries.
Read More
14 Apr 2021
Zoll Medical Acquires CSA Systems Manufacturer Respicardia
 ZOLL Medical Corporation (Chelmsford, MA, USA), an Asahi Kasei company, has acquired Respicardia, Inc. (Minnetonka, MN, USA), a provider of novel implantable neurostimulators for the treatment of moderate to severe Central Sleep Apnea (CSA).
Read More
13 Apr 2021
DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space
DiaSorin S.p.A. (?Saluggia?, Italy) has announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (Austin, TX, USA) for approximately USD 1.8 billion.
Read More
13 Apr 2021
Philips Collaborates with AI Startup Ibex to Accelerate Adoption of AI-Powered Digital Pathology Solutions
Royal Philips (Amsterdam, The Netherlands) and Ibex Medical Analytics (Tel Aviv, Israel) have entered into a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions